HSIC heads into Q3 with solid gains expected across Dental, Specialty and Tech segments, though earnings estimates have slipped slightly.

Henry Schein, Inc. (HSIC), based in Melville, New York, is a leading global provider of healthcare products and services for ...

Biomerica (BMRA) announced today a marketing services arrangement with Henry Schein (HSIC) to market Biomerica’s inFoods Irritable Bowel Syndrome, IBS, test in the United States, excluding New York ...

Henry Meds is a subscription-based telehealth platform that focuses on treatment for endocrine-related conditions. Offerings ...

This was the stock's second consecutive day of gains.

The nice thing about HSAs is that they're triple tax-advantaged. Your money goes in on a pre-tax basis, investment gains in ...

Over my more than 45 years in health care (I became president and CEO of Henry Ford Health in 2022), I’ve seen how this ...

Premiums in employer health plans are rising. Medicare beneficiaries are confronting higher costs and fewer options with ...

One way to keep your retirement healthcare costs under control is to make smart Medicare decisions. But whether you're ...

Welcome to Wrinkles Week on the Strategist, where we’re deeply vetting skin-care solutions for anyone who’s looking to smooth ...

Henry Schein, Inc., (Nasdaq: HSIC) the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the ...

Allied Market Research published a report, titled, "Bone Regeneration Market - Global Opportunity Analysis and Industry ...